FBXL20 and cancer: More specifically regarding the UPS, RNAi-mediated ablation of FBXL20, an F-box protein that is part of an E3 ligase complex, results in increased levels of Puma as well as Bax, which further enhances the sensitivity of cancer cells to chemotherapeutic drugs [149].